Samsung Biologics to provide CDMO support for ‘bio-venture’ firm GI Innovation 09-May-2019 By Melissa Fassbender Samsung Biologics is providing contract development services for GI Innovation’s pipeline, with the first among five molecules to initiate development immediately, says company representative.